Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.

Lettlova S, Brynychova V, Blecha J, Vrana D, Vondrusova M, Soucek P, Truksa J.

Cell Physiol Biochem. 2018;46(6):2601-2615. doi: 10.1159/000489687. Epub 2018 May 7.

2.

ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

Vrana D, Hlavac V, Brynychova V, Vaclavikova R, Neoral C, Vrba J, Aujesky R, Matzenauer M, Melichar B, Soucek P.

Int J Mol Sci. 2018 Mar 15;19(3). pii: E868. doi: 10.3390/ijms19030868. Review.

3.

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.

Lemstrova R, Brynychova V, Hughes DJ, Hlavac V, Dvorak P, Doherty JE, Murray HA, Crockard M, Oliverius M, Hlavsa J, Honsova E, Mazanec J, Kala Z, Lovecek M, Havlik R, Ehrmann J, Strouhal O, Soucek P, Melichar B, Mohelnikova-Duchonova B.

Oncol Lett. 2017 Nov;14(5):5980-5988. doi: 10.3892/ol.2017.6946. Epub 2017 Sep 14.

4.

Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas.

Kloudova A, Brynychova V, Vaclavikova R, Vrana D, Gatek J, Mrhalova M, Kodet R, Soucek P.

Clin Endocrinol (Oxf). 2017 Jun;86(6):852-861. doi: 10.1111/cen.13337. Epub 2017 Apr 24.

PMID:
28342201
5.

Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patients.

Brynychova V, Ehrlichova M, Hlavac V, Nemcova-Furstova V, Pecha V, Leva J, Trnkova M, Mrhalova M, Kodet R, Vrana D, Kovar J, Vaclavikova R, Gut I, Soucek P.

Biomed Pharmacother. 2016 Oct;83:857-864. doi: 10.1016/j.biopha.2016.07.047. Epub 2016 Aug 6.

PMID:
27505863
6.

Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters.

Němcová-Fürstová V, Kopperová D, Balušíková K, Ehrlichová M, Brynychová V, Václavíková R, Daniel P, Souček P, Kovář J.

Toxicol Appl Pharmacol. 2016 Nov 1;310:215-228. doi: 10.1016/j.taap.2016.09.020. Epub 2016 Sep 21.

PMID:
27664577
7.

Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target.

Brynychova V, Hlavac V, Ehrlichova M, Vaclavikova R, Nemcova-Furstova V, Pecha V, Trnkova M, Mrhalova M, Kodet R, Vrana D, Gatek J, Bendova M, Vernerova Z, Kovar J, Soucek P.

Clin Chem Lab Med. 2017 Jan 1;55(1):111-122. doi: 10.1515/cclm-2016-0271.

PMID:
27327132
8.

Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.

Vymetalkova V, Soucek P, Kunicka T, Jiraskova K, Brynychova V, Pardini B, Novosadova V, Polivkova Z, Kubackova K, Kozevnikovova R, Ambrus M, Vodickova L, Naccarati A, Vodicka P.

PLoS One. 2015 Jul 30;10(7):e0134463. doi: 10.1371/journal.pone.0134463. eCollection 2015.

9.

The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.

Hlaváč V, Brynychová V, Václavíková R, Ehrlichová M, Vrána D, Pecha V, Trnková M, Kodet R, Mrhalová M, Kubáčková K, Gatěk J, Vážan P, Souček P.

Medicine (Baltimore). 2014 Dec;93(28):e255. doi: 10.1097/MD.0000000000000255.

10.

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

Mohelnikova-Duchonova B, Brynychova V, Hlavac V, Kocik M, Oliverius M, Hlavsa J, Honsova E, Mazanec J, Kala Z, Melichar B, Soucek P.

Cancer Chemother Pharmacol. 2013 Sep;72(3):669-82. doi: 10.1007/s00280-013-2246-2. Epub 2013 Aug 11.

PMID:
23934321
11.

The expression profile of ATP-binding cassette transporter genes in breast carcinoma.

Hlaváč V, Brynychová V, Václavíková R, Ehrlichová M, Vrána D, Pecha V, Koževnikovová R, Trnková M, Gatěk J, Kopperová D, Gut I, Souček P.

Pharmacogenomics. 2013 Apr;14(5):515-29. doi: 10.2217/pgs.13.26.

PMID:
23556449
12.

The association of taxane resistance genes with the clinical course of ovarian carcinoma.

Ehrlichova M, Mohelnikova-Duchonova B, Hrdy J, Brynychova V, Mrhalova M, Kodet R, Rob L, Pluta M, Gut I, Soucek P, Vaclavikova R.

Genomics. 2013 Aug;102(2):96-101. doi: 10.1016/j.ygeno.2013.03.005. Epub 2013 Mar 28.

13.

Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression.

Brynychová V, Hlaváč V, Ehrlichová M, Václavíková R, Pecha V, Trnková M, Wald M, Mrhalová M, Kubáčková K, Pikus T, Kodet R, Kovář J, Souček P.

Future Oncol. 2013 Mar;9(3):427-38. doi: 10.2217/fon.12.200.

PMID:
23469978
14.

Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.

Mohelnikova-Duchonova B, Brynychova V, Oliverius M, Honsova E, Kala Z, Muckova K, Soucek P.

Pancreas. 2013 May;42(4):707-16. doi: 10.1097/MPA.0b013e318279b861.

PMID:
23462326

Supplemental Content

Loading ...
Support Center